abrdn International Small Cap Active ETF on Fagron NV
Thesis
The fund initiated Fagron because it views the company as a global leader in pharmaceutical compounding. Its business model is defensive and operates in a highly regulated market with significant barriers to entry. These characteristics support the fund's view that Fagron represents a compelling long-term growth opportunity.
“The company is a global leader in pharmaceutical compounding, offering a defensive and highly regulated business model with significant barriers to entry.”